Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

FGFR3 and FGFR4 do not mediate renal effects of FGF23.

Liu S, Vierthaler L, Tang W, Zhou J, Quarles LD.

J Am Soc Nephrol. 2008 Dec;19(12):2342-50. doi: 10.1681/ASN.2007121301.

2.

Genetic evidence of serum phosphate-independent functions of FGF-23 on bone.

Sitara D, Kim S, Razzaque MS, Bergwitz C, Taguchi T, Schüler C, Erben RG, Lanske B.

PLoS Genet. 2008 Aug 8;4(8):e1000154. doi: 10.1371/journal.pgen.1000154.

3.

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis.

Gutiérrez OM, Mannstadt M, Isakova T, Rauh-Hain JA, Tamez H, Shah A, Smith K, Lee H, Thadhani R, Jüppner H, Wolf M.

N Engl J Med. 2008 Aug 7;359(6):584-92. doi: 10.1056/NEJMoa0706130.

4.

Pathogenic role of Fgf23 in Dmp1-null mice.

Liu S, Zhou J, Tang W, Menard R, Feng JQ, Quarles LD.

Am J Physiol Endocrinol Metab. 2008 Aug;295(2):E254-61. doi: 10.1152/ajpendo.90201.2008.

5.

Anti-FGF23 neutralizing antibodies show the physiological role and structural features of FGF23.

Yamazaki Y, Tamada T, Kasai N, Urakawa I, Aono Y, Hasegawa H, Fujita T, Kuroki R, Yamashita T, Fukumoto S, Shimada T.

J Bone Miner Res. 2008 Sep;23(9):1509-18. doi: 10.1359/jbmr.080417.

6.

Direct binding of integrin alphavbeta3 to FGF1 plays a role in FGF1 signaling.

Mori S, Wu CY, Yamaji S, Saegusa J, Shi B, Ma Z, Kuwabara Y, Lam KS, Isseroff RR, Takada YK, Takada Y.

J Biol Chem. 2008 Jun 27;283(26):18066-75. doi: 10.1074/jbc.M801213200.

7.

A translocation causing increased alpha-klotho level results in hypophosphatemic rickets and hyperparathyroidism.

Brownstein CA, Adler F, Nelson-Williams C, Iijima J, Li P, Imura A, Nabeshima Y, Reyes-Mugica M, Carpenter TO, Lifton RP.

Proc Natl Acad Sci U S A. 2008 Mar 4;105(9):3455-60. doi: 10.1073/pnas.0712361105.

8.

Tumor producing fibroblast growth factor 23 localized by two-staged venous sampling.

van Boekel G, Ruinemans-Koerts J, Joosten F, Dijkhuizen P, van Sorge A, de Boer H.

Eur J Endocrinol. 2008 Mar;158(3):431-7. doi: 10.1530/EJE-07-0779.

9.

Overexpression of fibroblast growth factor 23 suppresses osteoblast differentiation and matrix mineralization in vitro.

Wang H, Yoshiko Y, Yamamoto R, Minamizaki T, Kozai K, Tanne K, Aubin JE, Maeda N.

J Bone Miner Res. 2008 Jun;23(6):939-48. doi: 10.1359/jbmr.080220.

10.

FGF23 is elevated in Gambian children with rickets.

Prentice A, Ceesay M, Nigdikar S, Allen SJ, Pettifor JM.

Bone. 2008 Apr;42(4):788-97. doi: 10.1016/j.bone.2007.11.014.

PMID:
18234575
11.

betaKlotho is required for fibroblast growth factor (FGF) 21 signaling through FGF receptor (FGFR) 1c and FGFR3c.

Suzuki M, Uehara Y, Motomura-Matsuzaka K, Oki J, Koyama Y, Kimura M, Asada M, Komi-Kuramochi A, Oka S, Imamura T.

Mol Endocrinol. 2008 Apr;22(4):1006-14. doi: 10.1210/me.2007-0313.

PMID:
18187602
12.

Aberrant Phex function in osteoblasts and osteocytes alone underlies murine X-linked hypophosphatemia.

Yuan B, Takaiwa M, Clemens TL, Feng JQ, Kumar R, Rowe PS, Xie Y, Drezner MK.

J Clin Invest. 2008 Feb;118(2):722-34. doi: 10.1172/JCI32702.

13.

Degradation of MEPE, DMP1, and release of SIBLING ASARM-peptides (minhibins): ASARM-peptide(s) are directly responsible for defective mineralization in HYP.

Martin A, David V, Laurence JS, Schwarz PM, Lafer EM, Hedge AM, Rowe PS.

Endocrinology. 2008 Apr;149(4):1757-72.

14.

Functional evolutionary history of the mouse Fgf gene family.

Itoh N, Ornitz DM.

Dev Dyn. 2008 Jan;237(1):18-27. Review.

15.

Insulin stimulates the cleavage and release of the extracellular domain of Klotho by ADAM10 and ADAM17.

Chen CD, Podvin S, Gillespie E, Leeman SE, Abraham CR.

Proc Natl Acad Sci U S A. 2007 Dec 11;104(50):19796-801.

16.

The parathyroid is a target organ for FGF23 in rats.

Ben-Dov IZ, Galitzer H, Lavi-Moshayoff V, Goetz R, Kuro-o M, Mohammadi M, Sirkis R, Naveh-Many T, Silver J.

J Clin Invest. 2007 Dec;117(12):4003-8.

17.

Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells.

Krajisnik T, Björklund P, Marsell R, Ljunggren O, Akerström G, Jonsson KB, Westin G, Larsson TE.

J Endocrinol. 2007 Oct;195(1):125-31.

18.

Gene expression analysis of kidneys from transgenic mice expressing fibroblast growth factor-23.

Marsell R, Krajisnik T, Göransson H, Ohlsson C, Ljunggren O, Larsson TE, Jonsson KB.

Nephrol Dial Transplant. 2008 Mar;23(3):827-33.

PMID:
17911089
19.

Parathyroid hormone regulates fibroblast growth factor-23 in a mouse model of primary hyperparathyroidism.

Kawata T, Imanishi Y, Kobayashi K, Miki T, Arnold A, Inaba M, Nishizawa Y.

J Am Soc Nephrol. 2007 Oct;18(10):2683-8.

20.

Distinct roles for intrinsic osteocyte abnormalities and systemic factors in regulation of FGF23 and bone mineralization in Hyp mice.

Liu S, Tang W, Zhou J, Vierthaler L, Quarles LD.

Am J Physiol Endocrinol Metab. 2007 Dec;293(6):E1636-44.

Items per page

Supplemental Content

Support Center